Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood-Based bandage may cut surgery complications in rare bladder condition

NCT ID NCT07294612

Disease control Sponsor: National Children's Medical Center, Uzbekistan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special material made from a child's own blood, called platelet-rich fibrin (PRF), can reduce complications after surgery for a rare bladder condition called bladder exstrophy. Twenty children having their first bladder repair surgery were split into two groups: one received PRF applied to the surgical site, and the other had standard surgery alone. The main goal was to see if PRF lowered the chance of developing a fistula (an abnormal opening) after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Jan 2022

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months to 18 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male patients diagnosed with primary bladder exstrophy-epispadias complex (BEEC) * Age from birth up to 18 years * Patients undergoing primary surgical repair of bladder exstrophy * Written informed consent provided by parents or legal guardians Exclusion Criteria: * Patients with cloacal variants of bladder exstrophy * Patients with complicated or recurrent bladder exstrophy * Patients who previously underwent bladder exstrophy repair * Patients with severe associated congenital anomalies that could affect wound healing * Patients with coagulation abnormalities * Patients with severe anemia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder exstrophy-epispadias complex are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bladder exstrophy Bladder Exstrophy and Epispadias Complex bladder exstrophy-epispadias-cloacal extrophy complex exstrophy-epispadias complex

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder exstrophy-epispadias complex

Contacts and locations

Locations

  • Zafar

    Tashkent, Tashkent, 100020, Uzbekistan